MeSH term
Frequency | Condition_Probility | Animals | 23 | 0.0 |
Female | 19 | 0.0 |
Male | 20 | 0.0 |
Mice | 16 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Mice, Mutant Strains | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 38 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 11 | 0.0 |
Tyrosine/*metabolism | 6 | 1.0 |
Humans | 54 | 0.0 |
Quebec/epidemiology | 2 | 6.0 |
DNA Mutational Analysis | 6 | 0.0 |
Hydrolases/*genetics/metabolism | 3 | 37.0 |
Infant | 9 | 0.0 |
Mutation | 6 | 0.0 |
*Mutation, Missense | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Tyrosinemias/*genetics/metabolism | 2 | 100.0 |
Amino Acid Sequence | 9 | 0.0 |
Blotting, Western | 3 | 0.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Molecular Sequence Data | 19 | 0.0 |
Rats | 7 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Base Sequence | 18 | 0.0 |
Cell Line | 5 | 0.0 |
DNA Primers | 4 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Models, Molecular | 3 | 0.0 |
Protein Conformation | 3 | 0.0 |
Acute Disease | 3 | 0.0 |
Alleles | 5 | 0.0 |
Biological Markers | 2 | 0.0 |
Chronic Disease | 3 | 0.0 |
Comparative Study | 5 | 0.0 |
Genes, Lethal | 2 | 2.0 |
Hydrolases/deficiency/*genetics | 8 | 100.0 |
Kidney/enzymology | 2 | 1.0 |
Liver/enzymology | 7 | 1.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Mutagenesis | 2 | 0.0 |
*Point Mutation | 2 | 0.0 |
RNA Splicing/genetics | 2 | 1.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Binding Sites | 2 | 0.0 |
Crystallography, X-Ray | 2 | 0.0 |
Cyclohexanones/therapeutic use | 2 | 100.0 |
Enzyme Inhibitors/therapeutic use | 2 | 2.0 |
Liver Transplantation | 5 | 8.0 |
Nitrobenzoates/therapeutic use | 2 | 100.0 |
Pedigree | 7 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Pregnancy | 3 | 0.0 |
*Apoptosis | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Adolescent | 3 | 0.0 |
Amino Acid Metabolism, Inborn Errors/enzymology/*genetics | 4 | 22.0 |
Child | 5 | 0.0 |
Child, Preschool | 7 | 0.0 |
Genotype | 4 | 0.0 |
Heterozygote | 3 | 0.0 |
Homozygote | 4 | 0.0 |
Infant, Newborn | 4 | 0.0 |
Tyrosine/*blood | 20 | 51.0 |
DNA | 2 | 0.0 |
Hydrolases/*genetics | 12 | 50.0 |
*Mutation | 7 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Amino Acid Metabolism, Inborn Errors/metabolism/*therapy | 2 | 66.0 |
Cell Transplantation | 2 | 2.0 |
Cells, Cultured | 5 | 0.0 |
Cyclohexanones/pharmacology | 2 | 33.0 |
Disease Models, Animal | 7 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
*Gene Therapy | 2 | 0.0 |
Nitrobenzoates/pharmacology | 2 | 22.0 |
Blotting, Southern | 3 | 0.0 |
Hydrolases/*deficiency/genetics | 4 | 100.0 |
Amino Acid Metabolism, Inborn Errors/*genetics | 6 | 16.0 |
Hydrolases/deficiency/genetics | 2 | 100.0 |
Genes, Recessive | 3 | 0.0 |
Exons | 5 | 0.0 |
Phenotype | 4 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Hydrolases/deficiency | 2 | 66.0 |
Amino Acid Metabolism, Inborn Errors/*enzymology | 3 | 50.0 |
Gene Frequency | 3 | 0.0 |
France/ethnology | 2 | 5.0 |
Haplotypes | 2 | 0.0 |
Heterozygote Detection | 2 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Prenatal Diagnosis | 2 | 1.0 |
Transfection | 3 | 0.0 |
Tyrosine/*blood/metabolism | 2 | 66.0 |
Amino Acid Metabolism, Inborn Errors/classification/enzymology/*genetics | 2 | 100.0 |
Chromosome Mapping | 3 | 0.0 |
DNA/genetics | 2 | 0.0 |
Gene Expression | 3 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 5 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Deoxyribonucleases, Type II Site-Specific/metabolism | 3 | 1.0 |
Rats, Inbred Strains | 2 | 0.0 |
Chromosomes, Human, Pair 15 | 3 | 2.0 |
Protein Biosynthesis | 3 | 0.0 |
Adult | 2 | 0.0 |
Hydrolases/*deficiency | 2 | 66.0 |
